Q-Gen Cell Therapeutics

Q-Gen Cell Therapeutics has more than 20 years of excellence in T-cell manufacturing supporting the immunotherapy industry. The facility offers advanced GMP cell manufacture. Q-Gen is a trusted partner for SMEs and public funded researchers seeking to translate a novel cell therapy to the market. Read more about Q-Gen here

UNSW RNA Institute

With the high-speed development of mRNA vaccines, brought on by rapid advances in the broader area of RNA biology and therapeutics, RNA products are being developed for a wide array of needs. From cancer treatments to diagnostics to agriculture, RNA science may hold the key to understanding some of the most complex scientific challenges. The […]

BASE mRNA Facility

mRNA vaccines and therapies provide a new strategy to treat disease.  The BASE facility makes mRNA for scientific research. This facility has experience making hundreds of mRNAs vaccines and therapies. BASE offers end-to-end services, including the design, manufacture and LNP formulation of mRNA, and also provide off-the-shelf mRNAs. Read more about BASE here

National Biologics Facility

The National Biologics Facility (NBF) enables Australian researchers to identify and translate their biomedical research discoveries, bridging the gap between early-stage development, testing and clinical supply for next-gen therapeutic candidates.  NBF is a Contract Research Organisation that for over 15 years has offered Australian researchers custom manufacturing solutions under phase-appropriate quality systems.   Read more about […]

Australian Translational Medicinal Chemistry Facility

The Australian Translational Medicinal Chemistry Facility (ATMCF) is a purpose-designed and outward-facing collaborative facility, translating new discoveries in disease biology into suitably targeted therapeutics for clinical development. ATMCF partners with suitable researchers and companies to efficiently and effectively address the multifaceted requirements of drug-discovery. Read more about ATMCF here

Centre for Drug Candidate Optimisation

The Centre for Drug Candidate Optimisation (CDCO) is a collaborative research centre based within the Monash Institute of Pharmaceutical Sciences. CDCO provides expertise and infrastructure in physicochemical property evaluation, drug metabolism and pharmacokinetics to multidisciplinary drug discovery teams for improved compound design, selection and progression. Read more about CDCO here

Compounds Australia

Compounds Australia, located within the Griffith Institute for Drug Discovery, provides cost-effective sample management and logistics throughout the drug discovery pipeline. By securely storing and curating sample libraries, Compounds Australia allows translational health researchers worldwide to outsource their sample and natural product logistics and focus on results. Read more about Compounds Australia here

Centre for Integrated Preclinical Drug Development

The Centre for Integrated Preclinical Drug Development (CIPDD) in the School of Biomedical Sciences, the Faculty of Medicine, has state-of-the-art physical infrastructure located in purpose-built facilities on the St Lucia Campus of The University of Queensland (UQ) and operated in accordance with the requirements of our Quality Management System. Read more about CIPDD here